多巴胺与去甲肾上腺素治疗感染性休克疗效比较的系统评价

被引:47
作者
赵阳 [1 ]
王倩 [2 ]
臧彬 [1 ]
机构
[1] 中国医科大学附属盛京医院ICU
[2] 中国医科大学附属第四医院急诊科
关键词
多巴胺; 去甲肾上腺素; 感染性休克; 随机对照试验; 系统评价; Meta分析;
D O I
暂无
中图分类号
R631.4 [];
学科分类号
1002 ; 100210 ;
摘要
目的系统评价多巴胺与去甲肾上腺素治疗感染性休克的疗效及安全性。方法计算机检索MEDLINE、EMbase、Cochrane图书馆、VIP、CNKI、CBM和WanFang Data等数据库(检索时限均从建库至2011年6月),纳入所有使用多巴胺或去甲肾上腺素治疗感染性休克的随机对照试验(RCT)。评价纳入研究的方法学质量和提取有效数据后,采用RevMan 5.1软件进行Meta分析。结果共纳入9个RCT,3 179例休克患者。Meta分析结果显示:多巴胺同去甲肾上腺素相比,能使感染性休克患者住院期间死亡风险增加12%,其差异具有统计学意义[RR=1.12,95%CI(1.04,1.21),P=0.002];多巴胺组感染性休克患者心率失常事件发生风险是去甲肾上腺素组的2.63倍[RR=2.63,95%C(I1.51,4.55),P=0.000 6];多巴胺组心脏指数较去甲肾上腺素组增加[MD=0.42,95%C(I0.21,0.63),P<0.000 1];但在心率[MD=17.05,95%CI(–0.71,34.81),P=0.06]及平均动脉压[MD=–0.87,95%CI(–24.97,7.62),P=0.30]方面,两组差异无统计学意义。结论去甲肾上腺素同多巴胺相比能显著降低感染性休克患者住院期间死亡率,降低心律失常事件的发生率,其疗效及安全性优于多巴胺。
引用
收藏
页码:679 / 685
页数:7
相关论文
共 7 条
[1]  
Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study)[J] . Pedro R. Póvoa,António H. Carneiro,Orquídea S. Ribeiro,Altamiro C. Pereira.Critical Care Medicine . 2009 (2)
[2]  
Inotropes and Vasopressors: Review of Physiology and Clinical Use in Cardiovascular Disease[J] . Circulation . 2008 (10)
[3]   Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study [J].
Sakr, Y ;
Reinhart, K ;
Vincent, JL ;
Sprung, CL ;
Moreno, R ;
Ranieri, VM ;
De Backer, D ;
Payen, D .
CRITICAL CARE MEDICINE, 2006, 34 (03) :589-597
[4]   Renal dose dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery [J].
Argalious, M ;
Motta, P ;
Khandwala, F ;
Samuel, S ;
Koch, CG ;
Gillinov, AM ;
Yared, JP ;
Starr, NJ ;
Bashour, CA .
CRITICAL CARE MEDICINE, 2005, 33 (06) :1327-1332
[5]  
EFFECTS OF DOPAMINE AND NOREPINEPHRINE ON SYSTEMIC AND HEPATOSPLANCHNIC HEMODYNAMICS, OXYGEN EXCHANGE, AND ENERGY BALANCE IN VASOPLEGIC SEPTIC PATIENTS[J] . Jean-Philippe Guérin,Jacques Levraut,Corine Samat-Long,Xavier Leverve,Dominique Grimaud,Carole Ichai.Shock . 2005 (1)
[6]   Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J].
Dellinger, RP ;
Carlet, JM ;
Masur, H ;
Gerlach, H ;
Calandra, T ;
Cohen, J ;
Gea-Banacloche, J ;
Keh, D ;
Marshall, JC ;
Parker, MM ;
Ramsay, G ;
Zimmerman, JL ;
Vincent, JL ;
Levy, MM .
INTENSIVE CARE MEDICINE, 2004, 30 (04) :536-555
[7]   Effect of norepinephrine on the outcome of septic shock [J].
Martin, C ;
Viviand, X ;
Leone, M ;
Thirion, X .
CRITICAL CARE MEDICINE, 2000, 28 (08) :2758-2765